)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Acuvi
Acuvi (ACUVI) investor relations material
Acuvi Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary20 Oct, 2026
Executive summary
Q3 revenue was SEK 47.4m vs SEK 57.8m YoY; reported EBITDA was -SEK 0.3m and adjusted EBITDA was SEK 6.4m.
9M free cash flow reached SEK 10.2m vs -SEK 27.5m in 9M 2025; management prioritizes top-line growth and cash flow.
Financial highlights
Q3 gross profit was SEK 20.1m vs SEK 28.5m; reported gross margin was 42% vs 49% YoY.
Q3 reported EBITDA was -SEK 0.3m vs SEK 6.7m; EBIT was -SEK 7.1m vs SEK 1.2m, with EBIT margin at -15% vs 2%.
Q3 net loss was SEK 8.2m vs SEK 2.6m; EPS was -SEK 0.25 vs -SEK 0.08.
9M revenue was SEK 148.7m vs SEK 150.6m; EBITDA was -SEK 1.3m vs SEK 26.4m and EBIT was -SEK 23.9m vs SEK 13.0m.
9M net loss was SEK 27.5m vs net income of SEK 5.1m; EPS was -SEK 0.83 vs SEK 0.16.
Outlook and guidance
Management expects PiezoMotor and Asian sales to offset much of the lost TPA Motion distribution business through the rest of 2026; PiezoMotor is expected to achieve or exceed 50% full-year growth.
Sales resources may be added at PiezoMotor and Sensapex, balancing growth initiatives with cost control; this may reduce earlier expectations for SEK 10m net cost savings.
Management expects positive cash flow to improve quarter by quarter, but gave no timing for sustainable positive cash flow excluding inventory effects.
IVF-instrument prototypes are progressing, with revenue possible as early as 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Acuvi
- Revenue up, margins down; strategic orders and leadership changes drive H2 outlook.ACUVI
Q2 2026 - Stable sales, lower margins, record PiezoMotor growth, and new U.S. defense orders shape outlook.ACUVIQ1 2026
- Q3 2025 revenue up 32% year-over-year, with robust OEM/Industrial growth and margin gains.ACUVIQ3 2025
- Net sales up 16%–18%, Q4 up 25%; adjusted EBITDA positive, 2026 targets focus on growth.ACUVIQ4 2025
- Direct sales focus and cash flow positivity set the stage for ambitious growth targets.ACUVIBusiness Update
- Q2 revenue and margins rose, driven by record orders and strategic direct sales expansion.ACUVIQ2 2025
- Stable Q3 margins, strong cash flow, and IFRS transition support positive 2024 outlook.ACUVIQ3 2024
- Sales declined but margins improved; new partnerships and capital support future growth.ACUVIQ2 2024
- Stark Q1-tillväxt och ökad direktförsäljning väntas driva fortsatt expansion.ACUVIQ1 2025
Next Acuvi earnings date
Q4 202625 Feb, 2027
Acuvi
Next Acuvi earnings date
Q4 202625 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Acuvi is a technology company specializing in micro- and nanotechnology-based products, including advanced motion and positioning systems. Its solutions are used in applications such as medical devices, diagnostics, and precision instruments. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq First North Growth Market.